Cargando…
Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism
BACKGROUND: Data on the effects of excess aldosterone on glucose metabolism are inconsistent. This study compared the changes in glucose metabolism in patients with primary aldosteronism (PA) after adrenalectomy or treatment with a mineralocorticoid receptor antagonist (MRA). METHODS: Overall, 241 p...
Autores principales: | Lin, Yu-Fang, Peng, Kang-Yung, Chang, Chia-Hui, Hu, Ya-Hui, Wu, Vin-Cent, Chung, Shiu-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Endocrine Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803597/ https://www.ncbi.nlm.nih.gov/pubmed/33261310 http://dx.doi.org/10.3803/EnM.2020.797 |
Ejemplares similares
-
Mineralocorticoid receptor antagonist treatment improved arterial
stiffness in patients with primary aldosteronism: a cohort study compared with
adrenalectomy
por: Liao, Che-Wei, et al.
Publicado: (2023) -
Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
por: Tezuka, Yuta, et al.
Publicado: (2021) -
Quality of Life of Primary Aldosteronism Patients by Mineralocorticoid Receptor Antagonists
por: Yoshida, Yuichi, et al.
Publicado: (2021) -
SAT-561 Effects of Mineralocorticoid Receptor Antagonists on Primary Aldosteronism Screening
por: Tezuka, Yuta, et al.
Publicado: (2020) -
PSUN68 Finerenone for Primary Aldosteronism: A Novel Mineralocorticoid Receptor Antagonist
por: Aurora, John, et al.
Publicado: (2022)